15231-48-8 Usage
Description
2-HYDROXY-4-METHYLPYRIMIDINE is an organic compound with the chemical formula C5H6N2O. It is a green-yellow solid that serves as an important intermediate in the synthesis of various chemical compounds, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
2-HYDROXY-4-METHYLPYRIMIDINE is used as a key intermediate for the synthesis of 2-Chloro-4-cyanopyrimidine, which is a crucial compound in the development of various pharmaceutical products. Its role in the synthesis process is essential for creating new and innovative medications that can address a wide range of health issues.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-HYDROXY-4-METHYLPYRIMIDINE is utilized as a building block for creating a variety of complex organic molecules. Its unique structure and reactivity make it a valuable component in the development of new compounds with potential applications in various industries, including agriculture, materials science, and environmental science.
Used in Research and Development:
2-HYDROXY-4-METHYLPYRIMIDINE is also employed in research and development laboratories, where it is used to study the properties and behavior of organic compounds. Its use in this context helps scientists gain a deeper understanding of chemical reactions and mechanisms, ultimately leading to the discovery of new compounds and materials with improved properties and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 15231-48-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,2,3 and 1 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 15231-48:
(7*1)+(6*5)+(5*2)+(4*3)+(3*1)+(2*4)+(1*8)=78
78 % 10 = 8
So 15231-48-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O/c1-4-2-3-6-5(8)7-4/h2-3H,1H3,(H,6,7,8)
15231-48-8Relevant articles and documents
Redox deracemization of phosphonate-substituted dihydropyrimidines
Feng, Guang-Shou,Guo, Xuan,Meng, Fan-Jie,Shao, Bing-Ru,Shi, Lei,Velopolcek, Maria K.
supporting information, p. 10570 - 10574 (2021/12/27)
An efficient redox deracemization of the phosphonic ester substituted 3,4-dihydropyrimidin-2-one (DHPM) derivatives is described. The one-pot deracemization strategy consisted of the oxidization to destroy the stereocenter center and the following asymmetric transfer hydrogenation to regenerate the chiral carbon center with the vicinal phosphonic ester group, providing a series of optically active phosphonate substituted DHPMs with up to 96% ee.
Investigation on possibility of rearrangement of pyrimidine-5-carboxylic acids esters
Scherbinina,Dar'In,Lobanov
, p. 1109 - 1115 (2011/10/02)
A previously reported rearrangement of pyrimidine-5-carboxylic acids esters to 5-acylpyrimidones does not, in fact, occur in any of the examples studied by us.
SUBSTITUTED N-HETEROCYCLIC COMPOUNDS AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS
-
Page/Page column 75, (2008/06/13)
The invention relates to the substituted N-heterocyclic compounds of general formula (I), wherein Ar, A1, X, Y, A2 and Q are defined as in claim 1, and to the tautomers of the compounds (I), the physiologically acceptable salts of compounds (I) and the physiologically acceptable salts of the tautomers of compound (I). The invention also relates to the use of these compounds and their pharmacologically acceptable salts in the production of a pharmaceutical agent for treating diseases that respond to the influence exerted by dopamine D3 receptor ligands, especially for treating diseases of the central nervous system, especially schizophrenia and/or depression.
